Deep 6 AI disrupts the clinical trial enrolment process by transforming the way researchers identify eligible patients. Using artificial intelligence and natural language processing to mine structured and unstructured patient data, DEEP 6 AI finds more, better-matching patients for trials in minutes, not months.
Deep 6 AI works with some of the most prominent health systems, pharma companies, and CROs in the world --making the DEEP 6 platform a crucial step in their clinical research workflow and greatly accelerating patients’ access to clinical trials.
Deep 6 AI was founded in 2015 and is based in Pasadena, CA.
Deep 6 AI are proud supporters of the AI Applications in Biopharma Summit.